Exlinkibart is under clinical development by Lyvgen Biopharma and currently in Phase I for Acral Lentiginous Melanoma.

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III drugs for Gastric Cancer have a 46% phase transition ...

Marley's cancer was an acral lentiginous melanoma, a rarer form that is not caused by sun exposure and often develops on the extremities. In 1977, when Marley was first diagnosed, this form of ...

In fact, people of color are at risk of a certain type of cancer called acral lentiginous melanoma, which is not directly caused by ultraviolet (UV) radiation exposure. (It was the type that killed ...

Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with ...

Nevus-associated acral melanoma was associated with better recurrence-free survival and overall survival rates compared with ...

In 2015, a person with metastatic melanoma — a form of skin cancer that has spread throughout the body — was unlikely to survive more than six months, and possibly not even six weeks if he or ...

“Below Deck Down Under” star Jason Chambers has been diagnosed with melanoma. The 52-year-old reality star publicly revealed his health news in an Instagram video on Monday. “Update on the ...

A PET scan can help doctors spot cancer that has spread through the body. A doctor may request one during the melanoma diagnostic process if they suspect advanced melanoma cancer. A PET scan is an ...

The FDA has approved cosibelimab, a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer. It is the first and only PD-L1 blocker approved to treat ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...